These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9514570)

  • 1. Clinical, microbiological and epidemiological aspects of Escherichia coli O157 infection.
    Coia JE
    FEMS Immunol Med Microbiol; 1998 Jan; 20(1):1-9. PubMed ID: 9514570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections.
    Karch H; Bielaszewska M; Bitzan M; Schmidt H
    Diagn Microbiol Infect Dis; 1999 Jul; 34(3):229-43. PubMed ID: 10403103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verocytotoxin-producing Escherichia coli infection in household members of children with hemolytic-uremic syndrome in The Netherlands.
    Heuvelink AE; Van de Kar NC; Van Der Velden TJ; Chart H; Monnens LA
    Pediatr Infect Dis J; 1999 Aug; 18(8):709-14. PubMed ID: 10462341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and pathogenic aspects of infections due to Escherichia coli O157:H7 and other verocytotoxigenic E. coli].
    Sánchez S; Martínez R; Alonso JM; Rey J
    Enferm Infecc Microbiol Clin; 2010; 28(6):370-4. PubMed ID: 19664858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.
    Kim YB; Okuda J; Matsumoto C; Morigaki T; Asai N; Watanabe H; Nishibuchi M
    FEMS Microbiol Lett; 1998 Sep; 166(1):43-8. PubMed ID: 9741083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enterohemorrhagic Escherichia coli and its infection: from 1977 to 1995].
    Takede Y
    Nihon Rinsho; 1997 Mar; 55(3):635-40. PubMed ID: 9086772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E. coli O157 infections.
    Gould LH; Mody RK; Ong KL; Clogher P; Cronquist AB; Garman KN; Lathrop S; Medus C; Spina NL; Webb TH; White PL; Wymore K; Gierke RE; Mahon BE; Griffin PM;
    Foodborne Pathog Dis; 2013 May; 10(5):453-60. PubMed ID: 23560425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.
    Mahon BE; Griffin PM; Mead PS; Tauxe RV
    Emerg Infect Dis; 1997; 3(3):409-12. PubMed ID: 9284395
    [No Abstract]   [Full Text] [Related]  

  • 9. VTEC O157 outbreak linked to beach holidays.
    Commun Dis Rep CDR Wkly; 1999 Sep; 9(37):327, 330. PubMed ID: 10495563
    [No Abstract]   [Full Text] [Related]  

  • 10. Verocytotoxin-producing Escherichia coli O157: public health and microbiological significance.
    Bolton FJ; Aird H
    Br J Biomed Sci; 1998 Jun; 55(2):127-35. PubMed ID: 10198471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
    Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
    Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli O157 in Somerset.
    Commun Dis Rep CDR Wkly; 1998 May; 8(19):167. PubMed ID: 9635338
    [No Abstract]   [Full Text] [Related]  

  • 13. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for the development of Escherichia coli O157:H7 associated with hemolytic uremic syndrome.
    Kawamura N; Yamazaki T; Tamai H
    Pediatr Int; 1999 Apr; 41(2):218-22. PubMed ID: 10221033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in virulence among Escherichia coli O157:H7 strains isolated from humans during disease outbreaks and from healthy cattle.
    Baker DR; Moxley RA; Steele MB; Lejeune JT; Christopher-Hennings J; Chen DG; Hardwidge PR; Francis DH
    Appl Environ Microbiol; 2007 Nov; 73(22):7338-46. PubMed ID: 17890332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Escherichia coli verotoxin (relationship between verotoxin produced by E. coli O157: H7 and HUS)].
    Matsunaga T; Komoda T
    Nihon Rinsho; 1999 Nov; 57 Suppl():172-5. PubMed ID: 10635805
    [No Abstract]   [Full Text] [Related]  

  • 17. A family outbreak of haemolytic uraemic syndrome and haemorrhagic colitis caused by verocytotoxigenic Escherichia coli O157 from unpasteurised cow's milk in Slovakia.
    Liptakova A; Siegfried L; Rosocha J; Podracka L; Bogyiova E; Kotulova D
    Clin Microbiol Infect; 2004 Jun; 10(6):576-8. PubMed ID: 15191389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enterohemorrhagic Escherichia coli O157 outbreak in Obihiro-city--biological and molecular characteristics among O157 isolates].
    Makino S; Asakura H; Shirahata T; Ikeda T; Takeshi K; Nagano H; Yano S; Kubota T; Fujii N
    Kansenshogaku Zasshi; 1997 Nov; 71(11):1131-6. PubMed ID: 9455053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Child care-associated outbreak of Escherichia coli O157:H7 and hemolytic uremic syndrome.
    Raffaelli RM; Paladini M; Hanson H; Kornstein L; Agasan A; Slavinski S; Weiss D; Fennelly GJ; Flynn JT
    Pediatr Infect Dis J; 2007 Oct; 26(10):951-3. PubMed ID: 17901803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enterohemorrhagic Escherichia coli O157:H7 infection].
    Rocchi G; Capozzi M
    Recenti Prog Med; 1999 Nov; 90(11):613-8. PubMed ID: 10608152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.